As the Global Safety Director at Amgen, Raul Inchausti plays a pivotal role in ensuring the highest standards of pharmacovigilance and safety compliance across the organization. With over 20 years of experience in the Life Sciences industry, Raul leverages his extensive knowledge of the drug...
As the Global Safety Director at Amgen, Raul Inchausti plays a pivotal role in ensuring the highest standards of pharmacovigilance and safety compliance across the organization. With over 20 years of experience in the Life Sciences industry, Raul leverages his extensive knowledge of the drug development process to lead strategic initiatives that enhance global regulatory compliance and optimize business processes. His expertise in safety and pharmacovigilance is critical as he oversees the integration of cutting-edge software solutions and services that streamline data management and reporting.
Raul's current projects focus on advancing Amgen's safety protocols through innovative software implementation and the development of high-performance teams. He is dedicated to fostering a culture of continuous improvement, where strategic thinking and resource allocation are paramount. By aligning safety initiatives with organizational goals, Raul ensures that Amgen not only meets regulatory requirements but also maintains its commitment to patient safety and product efficacy.
In addition to his technical skills in software development life cycle (SDLC) and consulting, Raul excels in account management and team management, driving collaboration across various departments. His ability to navigate complex regulatory landscapes while implementing effective safety strategies positions him as a key leader within Amgen. Through his work, Raul Inchausti is not only enhancing the company’s operational efficiency but also contributing to the broader mission of advancing healthcare and improving patient outcomes worldwide.
